Iterative cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: A multi-institutional experience.
Fiche publication
Date publication
décembre 2018
Journal
Journal of surgical oncology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr MARCHAL Frédéric, Pr BRIGAND Cécile
Tous les auteurs :
Alzahrani NA, Valle SJ, Fisher OM, Sugarbaker PH, Yonemura Y, Glehen O, Goere D, Honore C, Brigand C, de Hingh I, Verwaal VJ, Deraco M, Baratti D, Kusamura S, Pocard M, Piso P, Maerz L, Marchal F, Moran B, Levine EA, Dumont F, Pezet D, Abboud K, Kozman MA, Liauw W, Morris DL,
Lien Pubmed
Résumé
The aims of this multi-institutional study were to assess the feasibility of iterative cytoreductive surgery (iCRS)/hyperthermic intraperitoneal chemotherapy, iCRS in colorectal peritoneal carcinomatosis (CRPC), evaluate survival, recurrence, morbidity and mortality outcomes, and identify prognostic factors for overall survival.
Mots clés
colorectal peritoneal carcinomatosis (CRPC), hyperthermic intraperitoneal chemotherapy (HIPEC), iterative cytoreductive surgery (iCRS), prognostic factors, survival
Référence
J Surg Oncol. 2018 Dec 16;: